Melanotan-1

An alpha-MSH analogue approved as afamelanotide for erythropoietic protoporphyria and sold separately as a tanning peptide.

What research shows

Melanotan-1 is the compound behind afamelanotide, which holds marketing authorisation as Scenesse for a rare light-sensitivity condition and is delivered as a controlled implant. Randomized studies support light tolerance outcomes there. Material sold online for tanning is not that regulated product.

Evidence strength

Highest evidence grade among the graded claims: B. Grades reflect study strength, not benefit.

Safety context

See the safety section. Absence of a flag is not evidence of safety.

No endorsement

A grade reflects evidence strength, not a recommendation to use this compound; a strong grade can attach to a harmful effect.